ARCHIVES

Three Studies Demonstrate Oncotype DX Test Effectiveness

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Plans $61 Million For Six-Year Program In Biomarker Research For Early Detection

December 4, 1998

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

In Brief: Brian Henderson Names New Director Of USC Comprehensible Cancer Center, Norris Hospital

April 8, 1983

Letter to the Editors: BSA P01 Review Vote Was Advisory, NCI Official Says

December 5, 1997

OSCC Groups Send Four Concepts To NCI Board

September 13, 1985

NCI Relates FDA Instructions On Latest IND Delays

October 29, 1976